Alpine Associates Management’s Avidity Biosciences RNAM Stock Holding History

Alpine Associates Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-867,530	Closed	-$62.6M	–	97
2025 Q4	$62.6M	Buy	+867,530	New	+$56M	4.16%	9

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Alpine Associates Management's RNAM Position: Q1 2026 in Review

Alpine Associates Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 867,530 shares — an estimated $62.6M sold.

Alpine Associates Management first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $62.6M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Alpine Associates Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Alpine Associates Management sold 867,530 Avidity Biosciences shares in Q1 2026, an estimated $62.6M.
Alpine Associates Management first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
Alpine Associates Management's Avidity Biosciences position peaked at $62.6M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Alpine Associates Management's 13F filing for Q1 2026, filed 21 Apr 2026.